Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 179688-53-0
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Aluminum Foil Bag, Drum
Delivery Time: 7-15 days
Payment Terms: T/T, L/C, D/A, Western Union
Supply Ability: TON
CAS NO:: |
179688-53-0 |
Appearance:: |
Brown Solid Powder |
Molecular Formula:: |
C11H10N2O4 |
Molecular Weight:: |
234.20800 |
EINECS NO:: |
808-050-2 |
MDL NO:: |
MFCD09833010 |
CAS NO:: |
179688-53-0 |
Appearance:: |
Brown Solid Powder |
Molecular Formula:: |
C11H10N2O4 |
Molecular Weight:: |
234.20800 |
EINECS NO:: |
808-050-2 |
MDL NO:: |
MFCD09833010 |
Product Description:
Product Name: (7-metho-xy-4-oxo-1H-quinazolin-6-yl) acetate CAS NO: 179688-53-0
Synonyms:
6-Acetoxy-7-metho-xy-3,4-dihydroquinazolin-4-one;
6-Acetoxy-7-metho-xy-4-quinazolinol;
3,4-dihydro-4-oxo-6-acetyloxy-7-metho-xy-quinazoline;
Chemical & Physical Properties:
Appearance: Brown solid powder
Assay :≥99.0%
Density: 1.39
Boiling Point: 452.391℃ at 760 mmHg
Melting Point: 293℃
Flash Point: 227.398℃
Refractive Index: 1.612
Vapor Pressure: 0mmHg at 25℃
Safety Information:
HS Code: 2933990090
3, 4-dihydro-7-metho-xy-4-oxy quinazoline-6-alcohol acetate is a key intermediate for the synthesis of EGFR inhibitor Gefitinib and pan-HER inhibitor Poziotinib and other anti-tumor small molecules. 3, 4-dihydro-7-metho-xy-4-oxy quinazoline-6-alcohol acetate can be used as a pharmaceutical synthesis intermediate, can be prepared from 6-hydroxy-7-metho-xy-4-ketoquinazoline-as the reaction material, can be used to prepare the intermediate 7-metho-xy-6-acetoxy-4-chloroquinazoline-7-metho-xy. 3, 4-dihydro-7-metho-xy-4-oxy quinazoline-6-alcohol acetate is a white to light brown solid with strong inhibitory activity against VEGFR-2/HDAC and human breast cancer cell line MCF-7. Mainly used in pharmaceutical synthesis intermediates and cosmetics.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.